About the Editors

Pierre Beaulieu, MD, PhD, FRCA, is Associate Professor of Pharmacology and Anesthesiology at the University of Montréal, Québec, Canada. He received his MD at the University of Bordeaux, trained in anesthesiology in London, UK, and received his PhD in pharmacology in Montréal. His research concentrates on the pharmacology of cannabinoids in the treatment of pain through the modulation of the endocannabinoid system.
 
David Lussier, MD, obtained his medical degree from the University of Montréal and completed training in pain medicine and palliative care at Beth Israel Medical Center. He is now Associate Professor at University of Montréal, Adjunct Professor at McGill University, a member of McGill's Alan-Edwards Center for Research on Pain, and a physician at the University of Montréal Geriatric Institute and the McGill University Health Center.
 
Frank Porreca, PhD, is Professor of Pharmacology and Anesthesiology at the University of Arizona. He received his MS in biomedical engineering at Drexel University and his PhD in pharmacology at Temple University. His current research includes mechanisms of neuropathic and other chronic pains, headache pain, opioid-induced hyperalgesia, and new modalities for treatment of pain and drug abuse.
 
Anthony Dickenson, PhD, FMedSci, is Professor of Neuropharmacology in the Department of Pharmacology at University College, London, UK. He gained his PhD at the National Institute for Medical Research, London, and was appointed to the Department of Pharmacology at University College in 1983. He is a founding and continuing member of the Wellcome Trust-funded London Pain Consortium.